|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 5)*
|
Aquestive Therapeutics, Inc. (Name of Issuer) |
Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) |
(CUSIP Number) |
10/07/2026 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
| Rule 13d-1(c)
|
 Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
BRATTON DOUGLAS K | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
691,873.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.6 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: 390,795 shares are held by Bratton Capital Management L.P.; 875 shares are held by Bratton Capital Inc.; and 33,727 shares are held by Bratton Family Partners L.P. In his capacity as (i) the sole director and President of Bratton Capital Inc., which is the general partner of Bratton Capital Management L.P., Douglas K. Bratton ("DKB"), exercises voting and dispositive power over an aggregate of 391,670 shares held by Bratton Capital Inc. and Bratton Capital Management L.P. and (ii) the sole director and President of DKB Management, Inc., which is the general partner of Bratton Family Partners L.P., DKB exercises voting and dispositive power over the 33,727 shares held by Bratton Family Partners L.P. The number 637,823 also includes 212,426 shares owned directly by DKB or by family trusts and entities.
The number 691,873 includes 212,426 shares either owned directly by DKB or held by family trusts and entities, and 54,050 shares that DKB currently has the right to acquire under vested director stock options. It does not include 2,727 shares owned by DKB's spouse, with respect to which DKB disclaims beneficial ownership.
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
MonoLine RX II, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
TEXAS
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
Comment for Type of Reporting Person: Between October 2, 2026 and October 7, 2026, MonoLine RX II, L.P. distributed the 3,468,747 shares held by it to its owners.
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
MonoLine RX III, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
TEXAS
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
Comment for Type of Reporting Person: Between October 2, 2026 and October 7, 2026, MonoLine RX III, L.P. distributed the 2,657,943 shares held by it to its owners.
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
MonoLine RX, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
TEXAS
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
Comment for Type of Reporting Person: Between October 2, 2026 and October 7, 2026, MonoLine RX, L.P. distributed the 1,688,639 shares held by it to its owners.
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
MonoLine Partners, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
TEXAS
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
Comment for Type of Reporting Person: On October 2, 2026, MonoLine Partners, L.P. distributed the 1,948,578 shares held by it to its owners.
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
MonoSol Rx Genpar, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
TEXAS
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
Comment for Type of Reporting Person: Between October 2, 2026 and October 7, 2026, MonoSol RX Genpar, L.P. distributed the 47,051 shares held by it to its owners.
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
Bratton Capital Management, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
TEXAS
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
390,795.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.3 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
Bratton Capital Inc. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
TEXAS
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
391,670.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.3 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
CO |
Comment for Type of Reporting Person: 390,795 shares are held by Bratton Capital Management L.P. In its capacity as the general partner of Bratton Capital Management L.P., Bratton Capital Inc. exercises voting and dispositive power over such shares. 875 shares are held by Bratton Capital Inc. directly.
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
Bratton Family Partners L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
TEXAS
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
33,727.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
Aquestive Therapeutics, Inc. | |
| (b) | Address of issuer's principal executive offices:
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NEW JERSEY, 07059 | |
| Item 2. | ||
| (a) | Name of person filing:
Pursuant to Regulation 13D-G of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended (the "Act"), the undersigned hereby files this Schedule 13G Statement on behalf of MonoLine RX II, L.P., a Texas limited partnership ("MonoLine II"), MonoLine RX III, L.P., a Texas limited partnership ("MonoLine III"), MonoLine RX, L.P., a Texas limited partnership ("MonoLine RX"), MonoLine Partners, L.P., a Texas limited partnership ("Monoline"), MonoSol RX Genpar, L.P., a Texas limited partnership ("Genpar"), Douglas K. Bratton ("DKB"), Bratton Capital Management L.P., a Texas limited partnership ("Bratton Capital"), Bratton Capital Inc., a Texas corporation ("Bratton Inc."), and Bratton Family Partners L.P., a Texas limited partnership ("Bratton Family"), all of such persons and entities being referred to herein as the "Reporting Persons." Additionally, information is included herein with respect to DKB Management, Inc., a Texas corporation (the "Controlling Person"). The Reporting Persons and the Controlling Person are sometimes hereinafter collectively referred to as the "Item 2 Persons." The Item 2 Persons are making this single, joint filing because they may be deemed to constitute a "group" within the meaning of Section 13(d)(3) of the Act, although neither the fact of this filing nor anything contained herein shall be deemed to be an admission by the Item 2 Persons that such a group exists. | |
| (b) | Address or principal business office or, if none, residence:
The address of the principal business office of each of the Item 2 Persons is 201 Main Street, Suite 2100, Fort Worth, Texas 76102. | |
| (c) | Citizenship:
All of the natural persons listed in Item 2(a) are citizens of the United States of America. | |
| (d) | Title of class of securities:
Common Stock, Par Value $0.001 Per Share | |
| (e) | CUSIP No.:
| |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
Reporting Persons
DKB
Because of his position as (i) the sole director and President of Bratton Inc., which is the general partner of Bratton Capital, and (ii) the sole director and President of the Controlling Person, which is the general partner of Bratton Family, and his ownership of 266,476 shares held by him directly or by entities and trusts for the benefit of his immediate family, DKB may, pursuant to Rule 13d-3 of the Act, be deemed to be the beneficial owner of an aggregate of 691,873 shares of the Stock.
MonoLine II
The aggregate number of shares of the Stock that MonoLine II owns beneficially, pursuant to Rule 13d 3 of the Act, is 0.
MonoLine III
The aggregate number of shares of the Stock that MonoLine III owns beneficially, pursuant to Rule 13d 3 of the Act, is 0.
MonoLine RX
The aggregate number of shares of the Stock that MonoLine RX owns beneficially, pursuant to Rule 13d 3 of the Act, is 0.
MonoLine
The aggregate number of shares of the Stock that MonoLine owns beneficially, pursuant to Rule 13d 3 of the Act, is 0.
Genpar
The aggregate number of shares of the Stock that Genpar owns beneficially, pursuant to Rule 13d 3 of the Act, is 0.
Bratton Capital
The aggregate number of shares of the Stock that Bratton Capital owns beneficially, pursuant to Rule 13d 3 of the Act, is 390,795.
Bratton Inc.
Because of its position as the general partner of Bratton Capital and pursuant to its direct ownership of 875 shares of the Stock, Bratton Inc. may, pursuant to Rule 13d 3 of the Act, be deemed to be the beneficial owner of 391,670 shares of the Stock.
Bratton Family
The aggregate number of shares of the Stock that Bratton Family owns beneficially, pursuant to Rule 13d 3 of the Act, is 33,727.
Controlling Person
Because of its position as the general partner of Bratton Family, the Controlling Person may, pursuant to Rule 13d-3 of the Act, be deemed to be the beneficial owner of 33,727 shares of the Stock.
To the best of the knowledge of the Reporting Persons, other than as set forth above, none of the persons named in Item 2 herein is the beneficial owner of any shares of the Stock. | |
| (b) | Percent of class:
Reporting Persons
DKB
DKB may be deemed to be the beneficial owner of approximately 0.6% of the outstanding shares of the Stock.
MonoLine II
MonoLine II owns approximately 0.0% of the outstanding shares of the Stock.
MonoLine III
MonoLine III owns approximately 0.0% of the outstanding shares of the Stock.
MonoLine RX
MonoLine RX owns approximately 0.0% of the outstanding shares of the Stock.
MonoLine
MonoLine owns approximately 0.0% of the outstanding shares of the Stock.
Genpar
Genpar owns approximately 0.0% of the outstanding shares of the Stock.
Bratton Capital
Bratton Capital owns approximately 0.3% of the outstanding shares of the Stock.
Bratton Inc.
Bratton Inc. owns approximately 0.3% of the outstanding shares of the Stock.
Bratton Family
Bratton Family owns approximately 0.03% of the outstanding shares of the Stock.
Controlling Person
The Controlling Person may be deemed to be the beneficial owner of approximately 0.03% of the outstanding shares of the Stock.
To the best of the knowledge of the Reporting Persons, other than as set forth above, none of the persons named in Item 2 herein is the beneficial owner of any shares of the Stock. %
| |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
Reporting Persons
DKB
DKB has the sole power to vote or to direct the vote of an aggregate of 637,823 shares of the Stock, including (i) 391,670 shares in his capacity as the sole director and President of Bratton Inc., which is the general partner of Bratton Capital, and (ii) 33,727 shares in his capacity as the sole director and President of the Controlling Person, which is the general partner of Bratton Family.
MonoLine II
MonoLine II has the sole power to vote or to direct the vote of 0 shares of the Stock.
MonoLine III
MonoLine III has the sole power to vote or to direct the vote of 0 shares of the Stock.
MonoLine Rx
MonoLine Rx has the sole power to vote or to direct the vote of 0 shares of the Stock.
MonoLine
MonoLine has the sole power to vote or to direct the vote of 0 shares of the Stock.
Genpar
Genpar has the sole power to vote or to direct the vote of 0 shares of the Stock.
Bratton Capital
Acting through its general partner, Bratton Capital has the sole power to vote or to direct the vote of 390,795 shares of the Stock.
Bratton Inc.
In its capacity as the general partner of Bratton Capital and pursuant to its direct ownership of shares of the Stock, Bratton Inc. has the sole power to vote or to direct the vote of 391,670 shares of the Stock.
Bratton Family
Acting through its general partner, Bratton Family has the sole power to vote or to direct the vote of 33,727 shares of the Stock.
Controlling Person
In its capacity as the general partner of Bratton Family, the Controlling Person has the sole power to vote or to direct the vote of 33,727 shares of the Stock. | ||
| (ii) Shared power to vote or to direct the vote:
Reporting Persons
DKB
DKB has no shared power to vote or to direct the vote of any shares of the Stock.
MonoLine II
MonoLine II has no shared power to vote or to direct the vote of any shares of the Stock.
MonoLine III
MonoLine III has no shared power to vote or to direct the vote of any shares of the Stock.
MonoLine RX
MonoLine RX has no shared power to vote or to direct the vote of any shares of the Stock.
MonoLine
MonoLine has no shared power to vote or to direct the vote of any shares of the Stock.
Genpar
Genpar has no shared power to vote or to direct the vote of any shares of the Stock.
Bratton Capital
Bratton Capital has no shared power to vote or to direct the vote of any shares of the Stock.
Bratton Inc.
Bratton Inc. has no shared power to vote or to direct the vote of any shares of the Stock.
Bratton Family
Bratton Family has no shared power to vote or to direct the vote of any shares of the Stock.
Controlling Person
The Controlling Person has no shared power to vote or to direct the vote of any shares of the Stock. | ||
| (iii) Sole power to dispose or to direct the disposition of:
Reporting Persons
DKB
DKB has the sole power to dispose or to direct the disposition of an aggregate of 637,823 shares of the Stock, including (i) 391,670 shares in his capacity as the sole director and President of Bratton Inc., which is the general partner of Bratton Capital, and (ii) 33,727 shares in his capacity as the sole director and President of the Controlling Person, which is the general partner of Bratton Family.
MonoLine II
MonoLine II has the sole power to dispose or to direct the disposition of 0 shares of the Stock.
MonoLine III
MonoLine III has the sole power to dispose or to direct the disposition of 0 shares of the Stock.
MonoLine RX
MonoLine RX has the sole power to dispose or to direct the disposition of 0 shares of the Stock.
MonoLine
MonoLine has the sole power to dispose or to direct the disposition of 0 shares of the Stock.
Genpar
Genpar has the sole power to dispose or to direct the disposition of 0 shares of the Stock.
Bratton Capital
Acting through its general partner, Bratton Capital has the sole power to dispose or to direct the disposition of 390,795 shares of the Stock.
Bratton Inc.
In its capacity as the general partner of Bratton Capital and pursuant to its direct ownership of shares of the Stock, Bratton Inc. has the sole power to dispose or to direct the disposition of 391,670 shares of the Stock.
Bratton Family
Acting through its general partner, Bratton Family has the sole power to dispose or to direct the disposition of 33,727 shares of the Stock.
Controlling Person
In its capacity as the general partner of Bratton Family, the Controlling Person has the sole power to dispose or to direct the disposition of 33,727 shares of the Stock. | ||
| (iv) Shared power to dispose or to direct the disposition of:
Reporting Persons
DKB
DKB has no shared power to dispose or to direct the disposition of any shares of the Stock.
MonoLine II
MonoLine II has no shared power to dispose or to direct the disposition of any shares of the Stock.
MonoLine III
MonoLine III has no shared power to dispose or to direct the disposition of any shares of the Stock.
MonoLine RX
MonoLine RX has no shared power to dispose or to direct the disposition of any shares of the Stock.
MonoLine
MonoLine has no shared power to dispose or to direct the disposition of any shares of the Stock.
Genpar
Genpar has no shared power to dispose or to direct the disposition of any shares of the Stock.
Bratton Capital
Bratton Capital has no shared power to dispose or to direct the disposition of any shares of the Stock.
Bratton Inc.
Bratton Inc. has no shared power to dispose or to direct the disposition of any shares of the Stock.
Bratton Family
Bratton Family has no shared power to dispose or to direct the disposition of any shares of the Stock.
Controlling Person
The Controlling Person has no shared power to dispose or to direct the disposition of any shares of the Stock. | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
|
Ownership of 5 percent or less of a class
| ||
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See attached exhibit. | ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
Not Applicable
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|